Nina Capital is a specialized venture capital firm founded in 2019 and based in Barcelona, Spain. The firm focuses exclusively on investing at the intersection of healthcare and technology, aiming to support need-driven founders in improving health outcomes and care provision.
Nina Capital primarily invests in early-stage health tech companies, providing pre-seed to seed+ funding. The firm is particularly interested in startups offering data-driven healthcare solutions, computing, networks, and digital and deep technologies. Their investment areas include diagnostics, medical devices, clinician training, healthcare infrastructure, and enhancing operational efficiency in hospitals.
In February 2025, Nina Capital announced the first close of its third fund, Fund III, at €50 million, bringing its total assets under management to over €100 million. This fund aims to invest in approximately 25 companies, with initial check sizes ranging from €250,000 to €1.5 million, and reserves allocated for follow-on investments. The fund's limited partners include Boston-based wealth management firm Seven Two Partners, as well as family offices and high-net-worth individuals from Europe and the United States.
Investment Strategy
Nina Capital employs a need-driven, value-based approach to healthcare innovation, informed by the Stanford Biodesign methodology. The firm seeks founders who combine a deep understanding of the complex healthcare ecosystem with engineering innovation, advanced data science, and IT-enabled products and services. Nina Capital aims to bridge the gap from founding to Series A, assisting startups in accessing global markets and scaling their solutions internationally.
Notable Investments
Nina Capital's portfolio encompasses 50 companies, including:
Notable Exits
As of February 2025, Nina Capital has achieved exits including:
